Fundraising Fox

Faraday Pharmaceuticals

Seattle, US · Founded 2013 · Delaware corporation · 3 known investors

faradaypharma.com ↗
Biotech

Founders & leadership

TK
Thomas KingDirector
BB
Brian BlackmanExecutive Officer
ST
Simon TullochExecutive Officer
SG
Steven GillisExecutive Officer, Director, Promoter
MR
Mark RothExecutive Officer, Director, Promoter
SH
Stephen HillExecutive Officer, Director
PH
Paulina HillDirector

Investors · 3

ARCH Venture PartnersChicago · $50K – $250M
OUP (Osage University Partners)Bala Cynwyd · $1M – $20M
Polaris PartnersreportedBoston · $500K – $5M

Reported raises · per SEC filings

Form D private placements
▶$52.8MraisedNov 2022 · 3 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Simon TullochExecutive Officer
  • Brian BlackmanExecutive Officer
  • Patrick RockExecutive Officer
  • Steven GillisDirector
  • Stephen HillExecutive Officer, Director
  • Terrance McGuireDirector
  • Lawrence GozlanDirector
  • Mark RothDirector, Promoter
  • Ronald KierpaExecutive Officer
Offering amount
$102.8M
Amount sold
$52.8M
First sale
Oct 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$25.1MraisedSep 2019 · 8 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Lawrence GozlanDirector
  • Brian BlackmanExecutive Officer
  • Simon TullochExecutive Officer
  • Thomas KingDirector
  • Steven GillisDirector
  • Mark RothDirector, Promoter
  • Stephen HillExecutive Officer, Director
Offering amount
$30.1M
Amount sold
$25.1M
First sale
Aug 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MraisedMar 2019 · 7 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Steven GillisDirector
  • Thomas KingDirector
  • Mark RothDirector, Promoter
  • Brian BlackmanExecutive Officer
  • Stephen HillExecutive Officer, Director
  • Simon TullochExecutive Officer
Offering amount
$10M
Amount sold
$5M
First sale
Mar 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$32.6MraisedFeb 2017 · 11 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas KingDirector
  • Brian BlackmanExecutive Officer
  • Paulina HillDirector
  • Simon TullochExecutive Officer
  • Steven GillisExecutive Officer, Director, Promoter
  • Mark RothExecutive Officer, Director, Promoter
  • Stephen HillExecutive Officer, Director
Offering amount
$32.8M
Amount sold
$32.6M
First sale
Jul 2014
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.